为了探讨肝动脉门静脉化疗对肝癌切除术后复发的预防价值，作者对我院１９８９～１９９３年手术切除的５９例肝癌患者进行临床研究，结果单纯肝切除组与肝切除加肝动脉门静脉化疗组的１年复发率分别为５４５％及２４３％（ｐ＜００５），２年复发率分别为７７３％及３７８％（ｐ＜００１），表明肝动脉门静脉化疗可以降低肝癌切除术后复发率。 To investigate the preventive value of hepatic arterial portal vein chemotherapy for recurrence after hepatectomy for hepatocellular carcinoma, the authors performed a clinical study of 59 patients with liver cancer who underwent surgical resection in our hospital from 1989 to 1993. The results were obtained from simple hepatectomy and hepatectomy plus hepatic arterial portal vein chemotherapy. The 1-year recurrence rates were 54.5% and 24.3%, respectively (p < 0.05). The 2-year recurrence rates were 77. 3% and 37.8%, respectively (p <0. 01), indicating that the hepatic arterial portal vein Chemotherapy can reduce the recurrence rate after resection of liver cancer.